MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.77
+1.71%Forward multiples
Based on analyst estimates
- P/E forward
- 60.64x
- P/E 2026E
- —
- P/E 2027E
- 35.56x
- P/E 2028E
- 21.99x
- P/S forward
- 2.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- 119.25x
- PEG TTM
- 1.23x
- Price / book
- 3.22x
- Price / sales
- 1.96x
- Price / cash flow
- 15.08x
Enterprise value
- Enterprise value
- $561.8M
- EV / sales
- 1.58x
- EV / EBITDA
- 23.71x
- EV / EBIT
- 64.19x
- Market cap
- $696.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026